We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 1,004

Washington Healthcare Update- 10 Dec, 2018
  • McGuireWoods Consulting LLC
  • USA
  • December 10 2018

On Dec. 6, bipartisan House and Senate members released draft legislation for the Food and Drug Administration (FDA) to regulate in vitro clinical


The Solicitor General Provides an Unexpected and Quicker Path to Victory for Gilead
  • Crowell & Moring LLP
  • USA
  • December 3 2018

Over seven months ago, the Supreme Court asked the Solicitor General for the views of the United States in Gilead Sciences, Inc. v. United States ex


DOJ Announces to the Supreme Court That it Will Seek to Dismiss False Claims Act Case, and Affirms Position on Materiality Under Escobar
  • Mintz
  • USA
  • December 3 2018

The United States Department of Justice (DOJ) filed an amicus curiae brief with the Supreme Court on November 30, 2018 in a closely watched False


Split Third Circuit Decision Revives Claims Arising From Fatal 2005 Cessna Crash
  • Cozen O'Connor
  • USA
  • November 12 2018

In a decision likely to have far-reaching effects in the aviation industry, the Third Circuit in Sikkelee v. Precision Airmotive Corp., F.3d -, 2018


On Prevention of Federal Fraud on the FDA Claims That Avoid Buckman
  • Reed Smith LLP
  • USA
  • October 29 2018

Private plaintiffs love to scream “fraud on the FDA”! Agency fraud is their magic potion for dissolving any FDA action that they don’t like. Just


Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads
  • Mintz
  • USA
  • October 17 2018

The Trump Administration is moving full speed ahead with its proposals under the Blueprint to Lower Drug Prices (the “Blueprint”). Earlier this week


Government Urges Reversal of Third Circuit Fosamax Decision
  • Reed Smith LLP
  • USA
  • October 9 2018

We would be hard pressed to think of a recent judicial decision we have blasted as hard or often as the Third Circuit’s Fosamax opinion. We deemed it


C.D. Cal. Dismisses Lexapro Suicide Case
  • Reed Smith LLP
  • USA
  • September 26 2018

The toughest thing about defending product liability cases is the occasional immersion in human misery. Securities and antitrust cases pose


Oral Argument Held in Deeming Rule Appeal by Nicopure Labs and Right to be Smoke-Free Coalition
  • Keller and Heckman LLP
  • USA
  • September 26 2018

On September 11, 2018, Nicopure Labs, LLC and the Right to be Smoke-Free Coalition (the “Appellants”) appeared for oral argument before a three-judge


U.S. Supreme Court Grants Certiori to Decide Whether FDA Excluded Warnings Pre-Empt State Law Claims
  • Cozen O'Connor
  • USA
  • June 28 2018

The U.S. Supreme Court today agreed to consider a Third Circuit ruling that revived litigation over Merck’s alleged failure to warn about a risk of